Bio-Path Holdings, Inc.
BPTH
$0.03
-$0.01-19.53%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -79.51% | -94.93% | -83.83% | -55.88% | -10.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -90.84% | -98.44% | -81.47% | 50.16% | -12.29% |
| Operating Income | 90.84% | 98.44% | 81.47% | -50.16% | 12.29% |
| Income Before Tax | 90.53% | 90.96% | 53.85% | -145.96% | 9.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 90.53% | 90.96% | 53.85% | -145.96% | 9.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.53% | 90.96% | 53.85% | -145.96% | 9.66% |
| EBIT | 90.84% | 98.44% | 81.47% | -50.16% | 12.29% |
| EBITDA | 91.01% | 98.43% | 81.77% | -50.07% | 11.82% |
| EPS Basic | 92.84% | 95.06% | 83.67% | 52.28% | 91.72% |
| Normalized Basic EPS | 92.75% | 95.91% | 83.66% | 52.28% | 91.72% |
| EPS Diluted | 92.84% | 95.06% | 83.67% | 52.28% | 91.72% |
| Normalized Diluted EPS | 92.75% | 95.91% | 83.66% | 52.28% | 91.72% |
| Average Basic Shares Outstanding | 32.29% | 83.25% | 182.43% | 415.38% | 991.50% |
| Average Diluted Shares Outstanding | 32.29% | 83.25% | 182.43% | 415.38% | 991.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |